GLP-1 combination therapy signals new benefits in psoriasis
GLP-1 combination therapy may bring added benefits to psoriasis patients, The Hill reports, though no trial design, cohort, or PASI endpoint accompanies the claim.
Topic
Psoriasis
Topic
Psoriasis
GLP-1 Drugs May Ease Psoriasis in Some Patients, Study Finds
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and…
Lilly's Zepbound Boosts Taltz Response in Psoriasis Study
Lilly reports Zepbound (tirzepatide) enhanced Taltz (ixekizumab) efficacy in a psoriasis study, a signal for combination therapy…
Case Report Puts Late-Onset Plaque Psoriasis in Older Adults in Focus
Dermatology Times' second case installment examines plaque psoriasis that first presents in an older adult, where comorbidities a…
Biologic Safety Myths in Elderly Psoriasis Patients Under Scrutiny
Age alone is not a contraindication to biologic therapy in psoriasis, yet elderly patients remain undertreated as safety myths pe…
Debunking Biologic Safety Myths in Elderly Psoriasis Patients
Age alone should not disqualify older psoriasis patients from biologics, argues a Dermatology Times analysis dismantling persiste…
Icotrokinra Sustains Psoriasis Skin Clearance Through 2 Years
Two-year ICONIC-LEAD data show oral IL-23 receptor antagonist icotrokinra sustained skin clearance in plaque psoriasis, strengthe…
GLP-1 Combination Therapy Signals New Benefits in Psoriasis
NewsNation reports GLP-1 combination therapy may unlock new benefits for psoriasis patients, extending the metabolic-skin overlap…
Review reframes AD and psoriasis as dynamic immune processes
A Frontiers review reframes atopic dermatitis and psoriasis as dynamic immune processes, arguing static histopathology misses imm…
Early Psoriatic Arthritis Screening Can Prevent Irreversible Damage
Dermatologists see psoriasis patients years before rheumatology does. Friedman argues that window is the chance to catch psoriati…